-
¹ØÓÚwelcome-ÇòËÙÌåÓý
-
-
ÐÂÎŶ¯Ì¬
-
-
-
Éç»áÔðÈÎ
-
Ͷ×ÊÕß¹Øϵ
²úÆ·ÖÐÐÄ
ÁªÏµwelcome-ÇòËÙÌåÓý
ÏúÊÛרÓãº
µØÖ·£º±±¾©Êк£µíÇøÎ÷Ó׿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã
Fmoc Amine PEG Amine, TFA Salt
²úÆ·´úºÅ£º
FMOC-PEG-NH2TFA
²úÆ·´¿¶È£º
¡Ý 95%
°ü×°¹æ¸ñ£º
1g, 10g, 100gµÈ£¨ÌØÊâ°ü×°ÐèÊÕÈ¡·Ö×°Óöȣ©
·Ö×ÓÁ¿£º
2000 Da,3500 Da, 5000 Da, 7500 DaµÈ
¹Ø¼ü´Ê£º
ËùÊô·ÖÀࣺ
¿ÆÑпͻ§Ó×ÅúÁ¿Ò»¼ü²É¹ºµØÖ·£¨Ó×ÓÚ5¿Ë£©
- ²úÆ·ÃèÊö
- ²Î¿¼Îļþ
-
¡¡¡¡welcome-ÇòËÙÌåÓý¿Æ¼¼³ö²úµÄÒìÜ̼×ÑõôÊ°±»ù¾ÛÒÒ¶þ´¼°·Èý·úÒÒËáÑβúÆ·Öк¬Óа·»ùÍż°Êܱ£»¤µÄ°·»ù£¬Í¨³£ÓÃ×÷Á½ÖÖ·ÖÆ绯ѧÎïÖʵĽ»Áª¼Á»ò¾àÀëÎï¡£´ËÒìÖ°ÄÜPEGÑÜÉúÎïÖеÄPEG²¿ÃÅ¿ÉÌṩˮÈÜÐÔ¡¢ÉúÎïÏàÈÝÐÔ¼°ÈáÐÔ¡£´Ë²úƷרÃÅÀûÓÃÓÚ¿¹ÌåżÁªÒ©Îï(ADC¡¯s)µÄ¿ª·¢¡£
²úÆ·±àÂë
²úÆ·´úºÅ
A5138
FMOC-PEG2000-NH2TFA
A5139
FMOC-PEG3500-NH2TFA
A5140
FMOC-PEG5000-NH2TFA
A5141
FMOC-PEG7500-NH2TFA
¡¡¡¡welcome-ÇòËÙÌåÓý¿Æ¼¼ÌṩFMOC-PEG-NH2TFA·Ö×ÓÁ¿2000 Da,3500 Da, 5000 Da, 7500 DaµÄ²úÆ·1¿ËºÍ10¿Ë°ü×°¡£
¡¡¡¡welcome-ÇòËÙÌåÓý¿Æ¼¼Ìṩ·Ö×°·þÎñ£¬±ØÒªÊÕÈ¡·Ö×°Óöȣ¬ÈôÊÇÄú±ØÒª·ÖװΪÆäËû¹æ¸ñÇëÓëÎÒÃÇÁªÏµ¡£
¡¡¡¡welcome-ÇòËÙÌåÓý¿Æ¼¼Í¬Ê±ÌṩÆäËû·Ö×ÓÁ¿µÄFMOC-PEG-NH2TFAÑÜÉúÎï²úÆ·£¬ÈçÄã±ØÒªÇëÓëÎÒ˾sales@jenkem.comÁªÏµ¡£
¡¡¡¡welcome-ÇòËÙÌåÓý¿Æ¼¼Ìṩ´óÅúÁ¿³ö²ú²úÆ·¼°GMP¼¶±ð²úÆ·£¬ÈçÐ豨¼ÛÇëÓëÎÒÃÇÁªÏµ¡£
-
¡¡¡¡References:
¡¡¡¡1. Soni, K.S., et al., Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer, Journal of Controlled Release, 2017, V. 264, P. 276-287.
¡¡¡¡2. Kim, H.C., et al., Folic Acid-Functionalized Polythiophene for Targeted Cellular Imaging, Journal of Nanoscience and Nanotechnology, 2016, 16:1, p. 189-195(7).
¡¡¡¡3. Fahrländer E., et al., PEGylated human serum albumin (HSA) nanoparticles: preparation, characterization and quantification of the PEGylation extent, Nanotechnology, 2015, 26(14):145103.
¡¡¡¡4. Desale, S.S., et al., Targeted delivery of platinum-taxane combination therapy in ovarian cancer, Journal of Controlled Release, 2015, 220B, P. 651-659.
²úƷѯ¼Û
welcome-ÇòËÙÌåÓý
EN
·þÎñÈÈÏߣº+86-010-82156767
ÏúÊÛרÓãº+86-010-62983737
²úÆ·Õ÷ѯ£ºsales@jenkem.com
µØÖ·£º±±¾©Êк£µíÇøÎ÷Ó׿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã
΢ÐŹ«¼ÒºÅ
΢ÐŹ«¼ÒºÅ